Private healthcare provider Spire Healthcare Group has reported good progress last year with positive momentum in its sales growth, particularly private revenue.

According to Spire, the performance has been underpinned by its continued investment in clinical quality and patient safety which has resulted in 83% of the company’s sites now rated Good or Outstanding by the Care Quality Commission or equivalent, up from 81% in mid-2019 and 76% at the end of 2018.

Further progress on cash generation in the second half of 2019 means Spire anticipates a year-end net bank debt position of about £330 million, down from £362.2 million in mid-2019 and £372.7 million at the end of 2018.

Spire expects to publish its preliminary results for 2019 on 5 March.